NCT04071587

Brief Summary

In this study, we want to examine the effect of a new treatment approach for patients with severe upper limb paresis in the subacute phase after stroke. Brain Computer Interface (BCI) driven functional electrical stimulation will be compared to conventional training.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Aug 2019

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 21, 2019

Completed
5 days until next milestone

Study Start

First participant enrolled

August 26, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 28, 2019

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2022

Completed
Last Updated

November 14, 2022

Status Verified

January 1, 2022

Enrollment Period

2.6 years

First QC Date

August 21, 2019

Last Update Submit

November 10, 2022

Conditions

Keywords

BCIupper limbsevere paresissubacute strokerehabilitation

Outcome Measures

Primary Outcomes (1)

  • Action Research Arm Test (ARAT)

    Upper limb function on a scale of 0 - 57 (best)

    Upper limb function 90 days after stroke

Secondary Outcomes (2)

  • Fugl-Meyer Assessment (UL)

    Upper limb impairment 90 days after stroke

  • Functional Independence Measure

    Functional independence 90 days after stroke

Other Outcomes (1)

  • Interviews

    Through study completion, an average of 6 months

Study Arms (2)

BCI training

EXPERIMENTAL

Patients randomized to this group will receive up to12 (minimum 8) sessions of BCI training with the RecoveriX system (gtec, Austria). The system combines EEG driven functional electrical stimulation with visual feedback. BCI training is provided as a part of standard training of the impaired upper limb.

Device: Brain Computer Interface training

Control

ACTIVE COMPARATOR

Patients randomized to this control group will receive standard physiotherapy and occupational therapy for their impaired upper limb.

Behavioral: Control

Interventions

Training with RecoveriX system.

BCI training
ControlBEHAVIORAL

Standard physiotherapy and occupational therapy according to clinical routines.

Control

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • First ever or former stroke without UL motor residuals as confirmed by CT and / or MRI
  • days to 60 days (+/- 3) after stroke onset
  • Severe paresis or paralysis defined as \< 13 on Action Research arm Test (ARAT)
  • Able to give informed consent
  • Able to comply with treatment protocol.

You may not qualify if:

  • Other conditions limiting functional use of the affected UL,
  • Psychiatric / behavioral conditions that interfere with compliance to the protocol, epilepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hammel Neurorehabilitation Centre and University Research Clinic

Hammel, Aarhus, 8450, Denmark

Location

MeSH Terms

Conditions

StrokeParesis

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Iris Brunner, PhD

    Aarhus University, Hammel Neurocenter

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
All assessments will be done by assessors blinded to treatment allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients are randomized to one of two treatment options, intervention or standard rehabilitation
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 21, 2019

First Posted

August 28, 2019

Study Start

August 26, 2019

Primary Completion

March 31, 2022

Study Completion

March 31, 2022

Last Updated

November 14, 2022

Record last verified: 2022-01

Locations